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Abstract:  
The TNF family ligand Ectodysplasin A (EDA) regulates the induction, morphogenesis and/or 
maintenance of skin-derived structures such as teeth, hair, sweat glands and several other glands. 
Deficiencies in the EDA - EDA receptor (EDAR) signalling pathway cause hypohidrotic 
ectodermal dysplasia (HED). This syndrome is characterized by the absence or malformation of 
several skin-derived appendages resulting in hypotrychosis, hypodontia, heat-intolerance, dry 
skin and dry eyes, susceptibility to airways infections and crusting of various secretions. The 
EDA-EDAR system is an important effector of canonical Wnt signalling in developing skin 
appendages. It functions by stimulating NF-κB-mediated transcription of effectors or inhibitors 
of the Wnt, Sonic hedgehog (SHH), Fibroblast growth factor (FGF) and Transforming growth 
factor beta (TGFβ) pathways that regulate interactions within or between epithelial and 
mesenchymal cells and tissues. In animal models of Eda-deficiency, soluble EDAR agonists can 
precisely correct clinically relevant symptoms with low side effects even at high agonist doses, 
indicating that efficient negative feedback signals occur in treated tissues. Hijacking of the 
placental antibody transport system can help deliver active molecules to developing foetuses in a 
timely manner. EDAR agonists may serve to treat certain forms of ectodermal dysplasia. 
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Ectodysplasin A and ectodermal dysplasias  
Ectodermal dysplasias comprise more than 180 different heritable syndromes affecting at least 
two ectodermal structures such as hair, teeth, nails or exocrine glands (Visinoni et al., 2009). The 
most common ectodermal dysplasia, X-linked hypohidrotic ectodermal dysplasia (XLHED), is 
characterized by missing or sparse hair (hypotrychosis), abnormal or missing teeth (hypodontia 
or anodontia), reduced sweating ability (hypohidrosis), and defects of various lipid- or mucus-
secreting glands. XLHED is caused by mutations of the ectodysplasin A (EDA) gene (Kere et al., 
1996). EDA mutations are also associated with selective tooth agenesis (STA), an inherited 
condition in which teeth only are affected, with no pathologic involvement of other ectodermal 
appendages (Mues et al., 2010). EDA is a TNF family ligand that binds to EDA receptor 
(EDAR). EDAR signals via an adaptor protein, EDAR-associated protein with a death domain 
(EDARADD). Mutations in the EDAR or EDARADD genes cause hypohidrotic ectodermal 
dysplasias identical to XLHED, except for their autosomal dominant or recessive modes of 
transmission (Headon et al., 2001; Headon and Overbeek, 1999). 
 
Ectodysplasin A 
The human EDA gene was first identified by positional cloning in XLHED patients and is 
located on the long arm of the X chromosome (Kere et al., 1996). EDA is a 391 amino acid 
residues-long membrane protein with a short intracellular domain, a transmembrane domain, a 
stalk region of uncharacterized function, a consensus furin cleavage sequence responsible for 
proteolytic processing of EDA, a short positively-charged sequence required for interactions with 
heparan-sulfate proteoglycans, a bi-partite collagen-like domain and a 150 amino acid residues-
long C-terminal TNF homology domain (THD) responsible for receptor binding (Fig. 1A). EDA 
transcripts undergo complicated splicing events giving rise to numerous EDA isoforms (up to 
nine in mouse keratinocytes), of which only the longest two, EDA1 and EDA2, contain the THD, 
interact with receptors and are known to be biologically active (Bayes et al., 1998; Hashimoto et 
al., 2006). EDA1 and EDA2 differ by two amino acid residues in the THD (Glu308 and Val309) 
as a result of differential usage of a splice donor site at the end of exon 7 (Fig. 1A) (Yan et al., 
2000). EDA1 binds to EDAR, while the 2 amino acid residues shorter EDA2 specifically 
interacts with another TNF receptor family member, XEDAR (Yan et al., 2000). EDA1, EDA2 
and their receptor binding specificity are conserved in mammals and birds (Kowalczyk-Quintas 
et al., 2014). XEDAR is a p53-induced gene with no obvious implications in ectodermal 
appendage development (Brosh et al., 2010; Newton et al., 2004). EDA mutations identified in 
XLHED patients touch several distinct regions of the protein that are therefore believed to be of 
functional importance (Schneider et al., 2001) (Fig. 1A). The first one lies at the beginning of the 
stalk region, but why this region is important for EDA expression or function is unknown. 
Interestingly, fishes that have evolved in fresh water display a dramatic reduction in their bony 
armour compared to ocean fishes of the same species, which is due to the selection of a low-
abundance allele of Eda that includes, among other polymorphisms, a Leu79Pro transition at the 
beginning of the stalk region (Colosimo et al., 2005). The second region is the furin consensus 
cleavage site, indicating that EDA1 must be released to a soluble form to display activity (Fig. 
1A, B). The third region is the THD. The THD forms homotrimers that can bind three individual 
receptors at each monomer-monomer interface (Hymowitz et al., 2003). XLHED- and STA-
causing mutations in this domain interfere either with trimer formation, or with receptor binding 
(Mues et al., 2010; Schneider et al., 2001). The fourth region is the collagen domain that serves 
to keep two or more EDA1 trimers in close proximity within the same molecule and therefore 
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potentiate its ability to stimulate EDAR signalling (Schneider et al., 2001; Swee et al., 2009) 
(Fig. 1A,B). Finally, the proteoglycan-binding domain of EDA, which is mostly coded by the 
very short exon 3, may restrict EDA diffusion in tissues once it is released in a soluble form 
(Swee et al., 2009) (Fig. 1B). Mutations in the proteoglycan-binding region have not been 
reported in XLHED patients, either because this interaction is not essential for the function of 
EDA, or because disruption of the interaction can be achieved neither with a single point 
mutation nor with exon 3 deletion, which would induce a frame shift. 
 
EDAR 
EDAR is a typical TNF receptor family member with a signal peptide, three cystein-rich 
domains (CRDs), a transmembrane domain and an intracellular region comprising a so-called 
“death domain” (Headon and Overbeek, 1999) (Fig. 1A). Most mutations in patients with 
autosomal HED are located within CRD2, which is involved in ligand binding, or within the 
death domain, which is involved in signal transmission (Fig. 1A). A function activating 
polymorphism (Val370Ala) found in the death domain of EDAR in East Asian and Native 
American populations is associated with a thicker hair phenotype (Mou et al., 2008; Sabeti et al., 
2007). In the death receptors Fas and TRAILR2, the death domain recruits Fas-associated protein 
with a death domain (FADD), that itself recruits and activates cystein proteases of the caspase 
family to execute apoptotic cell death. EDAR does not interact with FADD, but instead recruits 
EDARADD, another adaptor protein with a death domain (Headon et al., 2001) (Fig. 1A).  
 
EDAR activates canonical NF-kB 
Deficiencies for EDA, EDAR or for the adaptor protein EDARADD all induce HED with similar 
if not identical manifestations. EDARADD, unlike FADD, does not recruit caspases, but 
possesses consensus binding sites for TNF receptor associated factors (TRAFs), and in particular 
TRAF6 (Fujikawa et al., 2013; Headon et al., 2001). TRAF6 mediates the activation of the 
transcription factor NF-κB downstream of several TNF receptor family members (e.g. EDAR, 
RANK and CD40) or other receptors (IL1R, TLRs). Thus, Traf6-deficient mice do not only 
develop ectodermal dysplasia similar to Edar- or Edaradd-deficient mice, but also osteopetrosis, 
alymphoplasia -RANK signalling is essential for the generation of osteoclasts and lymph nodes-, 
B cell abnormalities -CD40 is important for B cell activation- and blunted signalling by IL1 
receptor and Toll-like receptors (Naito et al., 2002). TRAF6 is an E3 ubiquitin ligase that 
generates K63-linked polyubiquitin chains to which binds NEMO, the regulatory component of 
the inhibitor of NF-κB kinase (IKK) complex (Chen, 2012). NEMO is on the X chromosome. 
Although complete NEMO-deficiency causes a severe and lethal inflammatory skin phenotype in 
human males, hypomorphic NEMO mutations are viable and cause HED with 
immunodeficiency, sometimes complicated by osteopetrosis for reasons similar to those 
explained above for Traf6-deficiency (Smahi et al., 2002; Zonana et al., 2000). The crucial 
implication of NF-κB downstream of EDAR is demonstrated by the phenotype of IκBαΔN 
transgenic mice that express a non-phosphorylable, and therefore non-degradable form of a NF-
κB inhibitor. These mice suffer from HED, osteopetrosis and immunodeficiency (Schmidt-
Ullrich et al., 2001). In embryonic skin of wild type mice, NF-κB is activated in primary hair 
placodes (Schmidt-Ullrich et al., 2006). In Eda-deficient skin, there are no placodes and there is 
no NF-κB activation. Addition of ectopic recombinant EDA restores placodes and NF-kB signals 
in Eda-deficient skin, but not in IκBαΔN transgenic skin (Schmidt-Ullrich et al., 2006). At least 
for the formation of primary hair placodes, NF-κB activation downstream of EDAR is not only 
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required, but apparently also sufficient as placodes can be formed with other NF-kB stimulators 
such as TNF or LPS (Schmidt-Ullrich et al., 2006) (Table 1) (Fig. 2). Table 1 is a compilation of 
phenotypes observed upon genetic modifications of genes related to processes also regulated by 
EDAR-signalling. Figure 2 is a partial, naïve and certainly incorrect view of how these gene 
products may interact with each other in the early phases of hair and tooth development.  
 
The EDA - EDAR pathway is an important effector of Wnt signalling, and in turn promotes 
further Wnt signalling 
Primary hairs do not form in Edar-deficient or in Wnt signalling-deficient (deletion of β-catenin) 
mice (Headon and Overbeek, 1999; Huelsken et al., 2001). Early studies in conditional β-catenin 
knock-out mice, where β-catenin was deleted in epithelial cells with a Keratin14 promoter-
driven Cre recombinase, concluded that Wnt signalling might be downstream of EDAR, as Edar 
was the only placode marker still expressed in β-catenin-deficient E15.5 skin (Huelsken et al., 
2001). Also, Edar expression was unaffected in Lef-1-null skin and tooth buds (Laurikkala et al., 
2001; Laurikkala et al., 2002). This conclusion that Edar was not a Wnt-responsive gene was 
subsequently revised when β-catenin was deleted with another Keratin14 promoter-driven Cre 
recombinase with more precocious expression. Indeed, Edar expression and NF-κB activation in 
E14.5 skin was absolutely dependent on β-catenin activity in the epithelium, and Edar was 
characterized as a direct Wnt target gene (Zhang et al., 2009). Likewise, initial uniform 
expression of Eda is also Wnt-dependent (Durmowicz et al., 2002; Laurikkala et al., 2001; 
Zhang et al., 2009). Although Wnt signalling acts upstream of EDAR in primary hair placodes, 
maintenance of β-catenin activity in primary placodes at a later stage requires EDAR activity 
(Zhang et al., 2009). EDAR signalling induces expression of Wnt10b, a direct NF-κB target 
gene, which is a good candidate to mediate the second round of β-catenin signalling in placodes 
(Zhang et al., 2009). Interestingly, forced EDAR-signalling (by expression of a constitutively 
active LMP-EDAR fusion receptor) in primary hair placodes in the context of Wnt inhibition (by 
expression of the Wnt inhibitor DKK1) failed to rescue expression of EDAR target genes such as 
Shh, indicating that expression of Wnt-dependent genes other than Eda and Edar is required for 
successful EDAR signalling (Zhang et al., 2009) (Fig. 2). 
 
Development of skin-derived appendages 
Skin-derived appendages, such as hair, teeth, and mammary glands have different function and 
structure but share common developmental aspects. The first step of development is the 
formation of a thickening of the epithelial layer, the placodes, accompanied by the condensation 
of the underlying mesenchyme. Placodes are embryonic signalling centres that express signalling 
molecule such as Wnt, FGF, TGFβ, Hedgehog and TNF family proteins (Laurikkala et al., 2002; 
Mikkola, 2007). In the next step of development, placodes invaginate into the mesenchyme to 
form buds that further grow and develop in organ-specific manners. Interactions between the 
epidermal and underlying dermal cells and tissues are common and recurrent themes of skin-
derived organ development. 
 
Development of hair 
In mice, hair development occurs in three distinct and successive waves giving rise, respectively, 
to guard, awl and auchene, and zigzag hair types. The first wave of hair placodes is visible at 
E13.5, and the second and third are initiated at E16 and E18 (Schmidt-Ullrich and Paus, 2005). 
The placode is formed by a clustering of epidermal keratinocytes in response to a signal from the 
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dermis that could be Wnt or a Wnt inducer. Placodes express inducing molecules to re-enforce 
signalling, and inhibitors to prevent differentiation at the periphery of placodes until a regular 
array of hair follicles is established (Millar, 2002; Schmidt-Ullrich and Paus, 2005). Each 
placode induces underlying mesenchymal cells to aggregate and form the dermal condensate 
(Millar, 2002). This is followed by proliferation and down growth of epithelial cells into the 
dermis until they surround the dermal condensate that becomes the dermal papilla. Lateral 
communication between the dermal papilla and the follicular epithelium induces proliferation of 
epithelial matrix cells that give rise to different hair follicle lineages forming first the different 
cell types of the inner root sheath (Henley’s layer, Huxley’s layer and cuticle) and then those of 
the mature hair shaft (cuticle, medulla and cortex) (Millar et al., 1999). The inner root sheath is 
surrounded by the companion cell layer and by the outer root sheath that is contiguous and 
similar to the epidermal basal layer. 
 
Development of teeth 
In teeth, the odontogenic signal originates form the epithelium at E11. At E12, placode cells 
proliferate into the underlying mesenchyme to form a bud. At E13.5 the mesenchyme condenses 
around the bud, expresses signalling molecules and transcription factors and instructs the 
epithelium to form the primary enamel knot at the tip of the bud. The primary enamel knot is a 
non-proliferating signalling centre important to stimulate cell proliferation in surrounding 
tissues. The primary enamel knot thus regulates folding of the tooth epithelium in a cap-shaped 
structure at E14.5 (Dassule et al., 2000; Jernvall and Thesleff, 2000). At the bell stage (E16), the 
condensed mesenchyme -now called the dental papilla- is completely enclosed by the 
invaginating tooth epithelium. Enamel knots are transient structures that disappear by apoptosis 
at the end of the cap stage (Jernvall and Thesleff, 2000). Incisor tooth germs have a single 
enamel knot, whereas molars additionally form secondary enamel knots at the bell stage to fold 
the enamel epithelium again and form multi-cuspids teeth. The final tooth shape is defined by the 
folding of the inner enamel epithelium and by the growth of the dental papilla (Caton and 
Tucker, 2009). 
 
Wnt and Wnt inhibitors 
Wnt/β-catenin signalling is crucial for the development of ectodermal appendages at early and 
later stages of differentiation (Andl et al., 2002; Huelsken et al., 2001; Liu et al., 2008; Millar, 
2002; Schmidt-Ullrich and Paus, 2005; van Genderen et al., 1994). The canonical Wnt pathway 
requires β-catenin. When Wnt is absent, β-catenin is eliminated by the action of the AXIN 
complex, which triggers β-catenin to proteasomal degradation. When Wnt is present, it binds to 
Frizzled receptor and to LRP5/6 co-receptors, which recruit Dishevelled (DVL), resulting in 
LRP5/6 phosphorylation and recruitment of the AXIN complex. This inhibits β-catenin 
degradation. Accumulated β-catenin translocates to the nucleus where, in complex with T cell 
factor/lymphoid enhancer factor (LEF/TCF), it activates expression of Wnt target gene 
(MacDonald et al., 2009). Negative regulators of Wnt signalling include DKKs (Andl et al., 
2002) and Sostdc1 (also known as Ectodin or Wise) (Ahn et al., 2010; Narhi et al., 2012). Both 
negatively regulate LRP5/6 co-receptors and therefore Wnt signalling, either directly (Sostdc1) 
(Itasaki et al., 2003; Li et al., 2005; Lintern et al., 2009) or additionally via engagement of 
Kremens (DKKs) (Wang et al., 2008) (Fig.2). Dkks are Wnt- and NF-κB-responsive (Andl et al., 
2002; Fliniaux et al., 2008; Zhang et al., 2009), whereas Sostdc1 is activated by BMPR 
signalling (Laurikkala et al., 2003; Mou et al., 2006). Sostdc1 is also a BMP antagonist 
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(Laurikkala et al., 2003), but the phenotype of Sostdc1-deficient mice that is characterized by 
enlarged enamel knots, additional teeth, enlarged mammary buds, enlarged hair placodes and 
ectopic whiskers (Ahn et al., 2010; Kassai et al., 2005; Narhi et al., 2012), is probably due to an 
upregulation of the Wnt signalling pathway (Ahn et al., 2010; Narhi et al., 2012). Endogenous 
expression of Dkk1 in the dermal condensate is suppressed by DKK1 overexpression, suggesting 
that it is a direct target of Wnt signalling involved in a negative feedback loop (Andl et al., 
2002). 
 
TGFβ  family members BMP, Activin, and their inhibitors 
BMPs are known as placode inhibitors (Botchkarev et al., 1999), but also provide positive 
signals for the differentiation of inner root sheath cells (Kobielak et al., 2003), generation and 
decay of enamel knots (Jernvall et al., 1998) or differentiation of ameloblasts (Wang et al., 
2004). The action of BMP is restricted by expression of a range of antagonists: Sostdc1 
(Laurikkala et al., 2003), CTGF (also known as CCN2) (Mou et al., 2006; Pummila et al., 2007), 
Noggin (Botchkarev et al., 1999) and Follistatin (Wang et al., 2004). Cell responses to BMP are 
often regulated by gradients. In the hair follicle, Bmpr1a ablation prevents differentiation of 
matrix cells to inner root sheath cells, and therefore prevents hair shaft formation (Andl et al., 
2004; Kobielak et al., 2003). A model for the differentiation of matrix cells to inner root sheath 
cells takes into account the seemingly contradictory observations that BMPR1a signalling 
inhibits Lef-1 expression, yet is required for β-catenin/LEF-1 activation (Kobielak et al., 2003). 
In the hair follicle, the dermal papilla produces Noggin that inhibits BMP signalling in the 
nearby proliferating epithelial matrix cells. Inhibition of BMP signalling induces Lef1 and Bmp4 
expression in matrix cells, but β-catenin/LEF-1 activation does not take place in the absence of 
BMPR1a signalling, possibly due to down-regulated expression of Wnt receptors or to an other 
cause. Absence of Wnt signalling thus prevents differentiation of proliferating matrix cells. As 
proliferating cells move upwards and away from the source of Noggin, they start responding to 
their own BMP4 to become Wnt-responsive. Despite Lef-1 downregulation, stabilized LEF-1 
protein is sufficient to ensure efficient β-catenin/LEF-1 activation and expression of Wnt-
responsive genes (e.g. hair keratins, Foxn1, Msx1, Msx2 and GATA3) involved in the 
differentiation of matrix cells to inner root sheath cells, which themselves will give rise to hair 
shaft cells (Kobielak et al., 2003). 
ActivinβA is a TGFβ family member involved in tooth and whiskers formation (Ferguson et al., 
1998; Jhaveri et al., 1998; Matzuk et al., 1995). ActivinβA, its receptor ACTRII and its effector 
SMAD2 are all essential for the development of incisors and mandibular molars (Ferguson et al., 
1998; Ferguson et al., 2001). Follistatin inhibits ActivinβA (Jhaveri et al., 1998; Matzuk et al., 
1995; Wang et al., 2004) (Fig. 2). 
 
Sonic hedgehog 
Sonic hedgehog (SHH), a member of the Hedgehog family, is a secreted protein important for 
organizing dermal cells into a dermal condensate (Chiang et al., 1999; St-Jacques et al., 1998). 
At a subsequent developmental stage, it induces proliferation of epithelial cells (Dassule et al., 
2000; Hardcastle et al., 1998). Binding of SHH to Patched releases the inhibition imposed on 
Smoothened that in turn can convert the Gli transcription factors from transcriptional repressors 
to transcriptional activators (Fig. 2). 
 
FGF 
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FGFs promote cell growth and proliferation. The direct Wnt target genes FGF4 and FGF8 
produced in the epithelium are essential for tooth development (Kratochwil et al., 2002; Wang et 
al., 2009). Interestingly, FGF8 controls expression of activinβA, that is essential for mandibular 
(but not maxillary) molar development, and of the homeobox genes Dlx1 and Dlx2 that are 
required for maxillary (but not mandibular) molar development (Ferguson et al., 2001) (and 
references therein). In chickens, the scaleless mutation disrupts the Fgf20 gene and results in 
naked, featherless and scaleless birds (Wells et al., 2012). In mice, Fgf20 is required for the 
formation of dermal condensations in primary and most secondary developing hair follicles, 
resulting in mice with no guard, reduced awl and auchene, and normal zigzag hair, in addition to 
moderately abnormal teeth (Haara et al., 2012; Huh et al., 2013). MAPK activation by FGF 
receptors is inhibited by Sprouty proteins, which are commonly induced by FGF action (Fig. 2). 
 
Molecular targets of EDAR signalling 
EDA and EDAR are important for the development of some but not all placodes (Laurikkala et 
al., 2002; Schmidt-Ullrich et al., 2006). EDA plays a role for stabilizing primary hair placodes, 
more that initiating them, as suggested by the presence of transient hair pre-placodes at E14 in 
Eda-deficient skin (Mou et al., 2006; Schmidt-Ullrich et al., 2006). Even when EDAR signalling 
is dispensable for placode formation, it often regulates morphology of the appendage or gland 
(Hammerschmidt and Schlake, 2007; Pispa et al., 1999; Schmidt-Ullrich et al., 2006; Voutilainen 
et al., 2012; Wells et al., 2010). EDAR signalling potentially interacts with all major 
morphogenesis pathways (Fig. 2). EDAR regulates expression of Edar itself (Mou et al., 2006), 
Wnt10b (Zhang et al., 2009), Dkk4 (Fliniaux et al., 2008), Shh (Pummila et al., 2007), Ctgf (Mou 
et al., 2006; Pummila et al., 2007), Follistatin (Pummila et al., 2007) and Fgf20 (Haara et al., 
2012; Huh et al., 2013). BMP4 strongly inhibits Edar expression in embryonic skin and could 
explain its negative role on primary placode formation (Mou et al., 2006). The induction of BMP 
inhibitors may locally protect the placode from BMP action, while the immediately surrounding 
tissue down-regulates Edar (Mou et al., 2006). Production of Wnt inhibitors may also contribute 
to downregulate Edar and other relevant genes at the periphery of placodes. The absence of Shh 
and Fgf20 expression in primary hair pre-placodes of Eda-deficient skin, and reduced production 
in Eda-deficient enamel knots certainly explains much of the absence of guard hair and of the 
molar defects of Eda-deficient mice (Haara et al., 2012; Huh et al., 2013; Pispa et al., 1999; 
Pummila et al., 2007). In addition, the branching defect observed in salivary glands of Eda-
deficient mice can be rescued in cultured organ explants with ectopic SHH (Wells et al., 2010), 
supporting a relevant role for SHH downstream of EDAR.  
 
Mouse and dog models of X-linked hypohidrotic ectodermal dysplasia 
In the mouse, loss-of-function mutations of Eda cause the Tabby phenotype, which is the mouse 
counterpart of XLHED (Srivastava et al., 1996; Srivastava et al., 1997). Tabby mice have a 
single abnormal awl-like hair type, no hair on the tail, lack the fine hair behind the ears but have 
hair on the ear skin. They lack sweat glands, mebomian glands, tracheal glands and present more 
or less marked abnormalities in sebaceous glands, mammary glands and salivary glands 
(Gruneberg, 1971). 
A dog model of XLHED is also available (Casal et al., 1997), in which a mutation in a splice site 
of EDA prevents protein expression (Casal et al., 2005). Affected dogs lack sweat glands, have 
bald patches around the body and lack secondary hair. They present abnormal or missing teeth, 
suffer from dry eyes and from recurrent airways infections due to abnormal mucus secretion in 
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bronchi and trachea (Casal et al., 1997; Casal et al., 2005). Thus, HED dogs recapitulate several 
of the clinically relevant defects of XLHED patients. 
 
Pharmacological activators of EDAR 
Fc-EDA1 is an EDAR agonist. It is a fusion protein between the effector portion (Fc fragment) 
of human IgG1 and the C-terminal, THD domain of EDA1 (Gaide and Schneider, 2003). As the 
Fc is a dimer and the THD is a trimer, the fusion protein mainly assembles as hexamers 
containing three Fc and two THD (Fig. 1C). The protein lacks the difficult-to-express collagen 
domain of EDA, whose aggregating function is mimicked by fusion with the Fc. Fc-EDA1 also 
lacks the proteoglycan-binding portion that prevents access of recombinant EDA to relevant 
tissues in vivo upon intra-peritoneal administration (Swee et al., 2009). The Fc portion of Fc-
EDA1 is also important to a) enhance half-life of the protein in vivo, an effect that is well-known 
to be mediated by binding to neonatal Fc receptors (FcRn), and b) allow transport from the 
maternal circulation to the circulation of the foetus via the trans-placental antibody transport 
system, which allows exposure of foetuses to the protein in utero. Fc-EDA1 can substitute for 
endogenous EDA1 to correct many phenotypic abnormalities of Eda-deficient mice or dogs, 
including permanent teeth in mice and the secondary dentition in dogs (Casal et al., 2007; Gaide 
and Schneider, 2003; Mauldin et al., 2009). In dogs, post-natal administration of Fc-EDA1 had 
several direct clinical benefits: it permanently abolished the dry eye phenotype (reverted dogs no 
longer needed the chronic eye drop treatment required by affected dogs) and improved 
mucociliary clearance in the airways, a feature that correlated with a drastic reduction of airways 
infections and courses of antibiotic treatments (Casal et al., 2007). Several anti-EDAR antibodies 
raised in Edar-deficient mice display in vivo activities similar to that of Fc-EDA1 when 
administered to Eda-deficient mice or dogs (Kowalczyk et al., 2011). Several hallmarks of the 
reversion of Eda-deficient animals with EDAR agonists are worth mentioning. A first feature is 
the life-long phenotypic correction achieved by a short-course treatment, indicating that EDAR 
provides an inductive rather than a maintenance signal (Gaide and Schneider, 2003; Kowalczyk 
et al., 2011) (Fig. 3). However, hair and their associated sebaceous glands are known exceptions 
in which the EDA-EDAR pathway remains active and can be regulated in adult life (Cui et al., 
2003; Fessing et al., 2006) (CKQ and PS, unpublished data). The effect of chronic EDAR-
agonist treatment on hair and their associated sebaceous glands will be interesting to study in the 
future. A second important feature of treatment efficacy is its relatively narrow therapeutic 
window, which depends on the ability of developing tissues to respond to EDA (Gaide and 
Schneider, 2003). Finally, the surprising fidelity with which tooth morphology can be corrected 
in Eda-deficient animals treated with a vast excess of “artificial” soluble EDAR agonists is 
certainly due to the fact that EDAR expression and its ability to signal and initiate regulatory 
feed-forward and feed-back responses are all intact in Eda-deficient animals. Another example is 
the restoration, in mice, of tail hairs regularly arranged by groups of three, which is remarkable 
considering that the skin of the tail is completely naked in the absence of treatment (Gaide and 
Schneider, 2003; Kowalczyk et al., 2011). However, soluble agonists do not restore the 
characteristic morphology of zigzag hairs with three evenly spaced and well-marked kinks. 
These kinks find their origin in the asymmetric expression of Eda in matrix cells of the hair 
follicle, which periodically shifts from one side of the hair follicle to the other, while Edar is 
continuously expressed on both sides of the follicle (Hammerschmidt and Schlake, 2007). EDAR 
signalling in the follicle, as judged by Shh and Saa3 expression -Saa3 is a NF-κB responsive 
gene- reflects the Eda expression pattern, suggesting that EDA acts locally (Hammerschmidt and 
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Schlake, 2007), possibly because the proteoglycan-binding domain restricts the diffusion of 
soluble EDA (Swee et al., 2009). If this model is true, the prediction is that soluble agonists will 
never rescue zigzag hairs or any process that requires polarized expression of Eda.  
Of note, a clinical trial to test the efficacy of a human form of Fc-EDA1 has recently been 
initiated in newborn patients with XLHED. 
 
Pharmacological inhibitors of EDAR 
Recombinant or endogenous EDA1 can be inhibited in vitro or in vivo with a soluble decoy 
EDAR-Fc fusion protein containing the extracellular, receptor-binding domain of EDAR 
(Fessing et al., 2006; Swee et al., 2009) (Fig. 1C). Function-blocking anti-EDA monoclonal 
antibodies have been raised in Eda-deficient mice. They block EDA at close to stoichiometric 
ratio and can induce ectodermal dysplasia in mice (Kowalczyk-Quintas et al., 2014). The 
availability of monoclonal mouse antibodies able to block and/or activate EDAR signalling in 
vivo will be useful to study this pathway during or after development. 
 
Conclusion 
Ectodysplasin A1 and its receptor EDAR are important for the development and function of 
several, but not all, ectodermal appendages. This system is part of a complex process of cell 
communication and differentiation involved in morphogenesis, which has been best 
characterized during development of mouse teeth and primary hairs, but whose common themes 
also apply at least in part to other structures and species. EDAR signalling occurs rather late in 
development and affects a defined set of organs. Available genetic data identified much of the 
mechanism and implications of EDAR signalling. The availability of pharmacological 
modulators of the pathway raises hope to use this knowledge for the treatment of certain forms of 
ectodermal dysplasia. Modulation of the EDAR signalling pathway may also find applications in 
pathologies involving Edar-regulated glands and organs. 
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Table 1: Phenotype associated with altered expression of genes of ectodermal appendages, by 
alphabetical order of the genes. 
Protein 
Gene modification 
Remarks, phenotype Ref 
β-catenin 
one stabilized 
allele (Δex3) in 
K14 tissues  
Lethal at birth. Early hair placode initiation. Increased number 
of hair placodes (even without Eda), but suppressed follicle 
down growth. Limb and craniofacial abnormalities. Multiple 
mono-cuspid teeth. 
(Jarvinen et al., 
2006; Liu et al., 
2008; Narhi et al., 
2008; Zhang et al., 
2008) 
β-catenin 
K14-Cre;β-catenin 
(medium Cre) 
Viable. Block of hair development in β-catenin-deleted skin 
areas. Body hair that form are lost at 2 week of age.  
(Huelsken et al., 
2001; Zhang et al., 
2009) 
β-catenin 
K14-Cre;β-catenin 
(early Cre) 
Viability not mentioned. Block of hair development. Loss of 
patterned β-catenin activity in E13.5 to E14.5 dermis. 
(Huelsken et al., 
2001; Zhang et al., 
2009) 
ActivinβA 
ActivinβA-null 
Lethal at P1. No whiskers. Incisor and mandibular molar 
failed to develop beyond the bud stage. Maxillary molars 
unaffected. 
(Ferguson et al., 
1998; Jhaveri et al., 
1998; Matzuk et al., 
1995) 
ActivinRIIA+B 
ActRIIB-null 
+ActRIIA-het 
Lethal at birth. Similar to ActivinβA-null. Partial penetrance of 
tooth phenotype. 
(Ferguson et al., 
2001) 
BMPR1a 
K14-Cre;Bmpr1a 
(early Cre) 
Lethal at P1. Severe limb defects. Opened eyes. Accelerated 
hair placode development, but normal follicle number at birth. 
Mammary glands present. Tooth development arrest at bud 
stage (E13.5). No teeth. 
(Andl et al., 2004) 
BMPR1a 
K14-Cre;Bmpr1a 
(medium Cre) 
Lethal around P4. Ablation almost complete at E15.5. Normal 
limbs and eyes, runted, lack external hair, whiskers and teeth. 
Defective hair follicle (outer root sheath present, but inner root 
sheath does not form). Lef1 is expressed, but not Wnt-target 
genes. 
(Andl et al., 2004; 
Kobielak et al., 
2003) 
BMPR1a 
K14-Cre;Bmpr1a 
(late Cre) 
Survive up to several months. Runted. Decreased hair. (Andl et al., 2004) 
BMPR1a 
Brn4-Cre;Bmpr1a 
Survive 2 weeks. Deletion in neural tube, limb epithelium, 
ventral epidermis. Accelerated hair placode development, no 
hair shaft  no external hair in mid ventrum. CNS defects. 
(Andl et al., 2004) 
BMPR1a BMR1b 
Brn4-Cre;Bmpr1a 
+ Bmpr1b 
Same as Brn4-Cre32;BmprIa only ( Bmpr1a and Bmpr1b 
are not redundant). 
(Andl et al., 2004) 
DKK1 
K14::Dkk1 
high expression 
Lethal at birth. Expressed from E9.5. No hair development. 
No vibrissae. No Edar or Lef-1 expression. Block of molar 
and incisors development at the bud stage. Mammary gland 
development arrest at the bud stage. 
(Andl et al., 2002; 
Liu et al., 2008; 
Zhang et al., 2009)  
DKK1 
Foxn1::Dkk1  
high expression 
Viable. Gene expression in hair cortex, and weakly in 
epidermis. No hair follicles, except few guard hair follicles 
with no shaft (because Foxn1 promoter is activated late). 
(Hammerschmidt 
and Schlake, 
2007) 
DKK1 
Foxn1::Dkk1  
mild expression 
Viable. Gene expression from E14 to E14.5. Focal alopecia 
behind the ears. No sweat glands. Thin hair without bends, no 
zigzag hair. Guard hairs present but shorter. 
(Hammerschmidt 
and Schlake, 2007) 
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EDA 
Eda-deficiency 
Tabby mice. Viable. Alopecia behind the ears, no tail hair, no 
sweat glands, no mebomian glands, no tracheal glands, lack of 
several other glands, abnormal hair coat (only zigzag hair with 
abnormal awl-like morphology), smaller molars with fewer 
cusps, third molar sometimes lacking. Small eye opening, 
thickened eyelids. 
(Gruneberg, 1971; 
Hammerschmidt 
and Schlake, 2007; 
Pispa et al., 1999) 
EDA1 
Tet off::Eda1 
K14::Eda1 
Viable. No kinks in zigzag hairs, sebaceous gland hyperplasia, 
supernumerary teeth and nipples, continuous hair placode 
formation from E14 to birth. 
(Cui et al., 2003; 
Mustonen et al., 
2003) 
EDA2 
Tet off::Eda2 
K14::Eda2 
Viable. No phenotype in ectodermal appendages. (Cui et al., 2003; 
Mustonen et al., 
2003) 
EDAR 
Edar-deficiency 
Downless and Sleek mice. Viable. Same phenotype as Eda-
deficient mice. 
(Headon and 
Overbeek, 1999) 
EDAR 
Tg951 (~20 copies 
of YAC transgene) 
Sebaceous and mebomian glands are enlarged, salivary and 
mammary glands are more elaborately and more branched, 
enlarged hair follicles, thicker hair fiber. 
(Chang et al., 2009; 
Mou et al., 2008) 
EDARADD 
Edaradd-null 
Crinkled mice. Deletion. Viable. Same phenotype as Eda-
deficient mice. 
(Falconer et al., 
1951; Headon et al., 
2001) 
FGF20 
Fgf20-null 
(knock-in with 
βGal) 
Smaller molars, reduced crown area. No guard hair, reduced 
numbers of awl and auchene hair, normal zigzag hair. 
Placodes are generated for missing hair, but no dermal 
condensation form underneath. 
(Haara et al., 2012; 
Huh et al., 2013) 
FGF20 
Fgf20-deficiency 
Scaleless mutant in chicken. Non-sense mutation in Fgf20. No 
feathers and scales.  
(Wells et al., 2012) 
Follistatin 
K14::follistatin 
Viable. Inhibition of ameloblasts differentiation in incisors. 
No enamel. 
(Wang et al., 2004) 
Follistatin 
Follistatin-null 
Lethal soon after birth. Retarded growth. Diaphragm, muscle 
and skeletal defects. Shiny taut skin. Thin and curly whiskers. 
Molar cusps defects, ameloblasts differentiate ectopically on 
the lingual enamel-free surface of the incisor. 
(Jhaveri et al., 1998; 
Matzuk et al., 1995; 
Wang et al., 2004) 
GLI2, GLI3 
Gli2-null, Gli3-
null 
Lethal around E10.5, few embryos survive to E14.5. Incisors 
blocked at bud stage, no sign of molar development. 
(Hardcastle et al., 
1998) 
IκBα 
ki of IκBαΔN 
(super-repressor) 
in β-catenin locus 
Viable. Alopecia behind the ears, no tail hair, no sweat glands, 
no mebomian glands, abnormal hair coat (single awl-like hair 
type). Reduced number of hair follicles. Delayed outgrowth of 
incisors and molars. Abnormal incisor positioning. No lymph 
nodes, osteopetrosis, immuno-deficiency. 
(Ohazama et al., 
2004; Schmidt-
Ullrich et al., 2001; 
Schmidt-Ullrich et 
al., 2006) 
LEF-1 
K14::Lef1 
Viable. Aberrant patterning of the hair on the body. 
Inappropriate eruption of hair and tooth-like structures in the 
oral epithelium 
(Zhou et al., 1995) 
 
LEF-1 
Lef1-null 
Lethal at birth. Lack of vibrissae and body hair. Tail hair and 
sweat gland present. Tooth development arrest at bud stage. 
Lack of mammary gland 
(van Genderen et al., 
1994) 
 
NEMO/IKKγ 
mutations in 
human 
On the X chromosome. Complete deficiency is lethal. 
Heterozygous females develop incontinentia pigmenti. Males 
with hypomorphic mutations have hypohidrotic ectodermal 
dysplasia with immunodeficiency (HED-ID). Males with stop 
(Smahi et al., 2002; 
Zonana et al., 2000) 
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codon mutations have in addition osteopetrosis and 
lymphedema (OL-HED-ID). 
Noggin 
K14::Noggin 
 
Viable and fertile. Chicken Noggin. All hair types are present. 
Too many awls and auchenes. Hypertrophic sebaceous glands. 
Shorter telogen phase. Compound follicles with 2-3 vibrissae. 
Ectopic cilia instead of mebomian glands, small eyelid 
opening, smaller footpads with hair instead of sweat glands. 
No claws. Increased size of external genitalia in both sexes. 
(Plikus et al., 2004) 
 
Noggin 
K5::Noggin 
Increased size of anagen hair follicles, replacement of zigzag 
and auchene hairs by awl-like hairs (no more hair with bends). 
(Sharov et al., 2006) 
Noggin 
Noggin-null 
Reduced hair placode number. Hair development arrest at bud 
stage. 
(Botchkarev et al., 
1999) 
SHH 
Foxn1::Shh 
Viable. Expression mainly in hair cortex. Attenuation of kinks 
in zigzag hair attributed to altered polarity of follicles. 
(Hammerschmidt 
and Schlake, 2007) 
SHH 
Shh-null, and 
grafted embryonic 
null skin  
Lethal at birth. The first branchial arch giving rise to jaw 
mandibles does not form. Hair development blocked at 
placodes and dermal condensate stage. Reduced number of 
hair follicles. 
(Chiang et al., 1999; 
St-Jacques et al., 
1998) 
 
SHH 
K14-Cre;Shh 
Lethal at birth. Deletion at E12.5, (still expressed at E11.5). 
Opened eyes. No whiskers. Jaws present. Small and 
abnormally shaped incisors and molars. Defect at cap stage 
(E14.5), functional enamel knot, severe defect of epithelial 
cells downgrowth on the lingual side where Shh is normally 
expressed). Ameloblasts and odontoblasts still differentiate. 
(Dassule et al., 
2000) 
SMAD2 
Smad2-het 
Lethal at birth. Similar to ActivinβA-null. Partial penetrance of 
tooth phenotype. 
(Ferguson et al., 
2001) 
Sostdc1 
Sostdc1-null 
Viable. Enlarge enamel knot, supplementary incisors and 
molars, fused molars and cusps defect. Enlarge hair and 
mammary placodes. Ectopic whiskers. 
(Ahn et al., 2010; 
Kassai et al., 2005; 
Narhi et al., 2012) 
Sostdc1/Ectodin 
K14::Sostdc1 
Viable. Reduced tooth size, loss of the M3 molar, and cusps 
defect. Abnormal development of hair follicle. 
(Ahn et al., 2010; 
Ahn et al., 2013) 
TRAF6 
Traf6-null 
Viable. No guard hair, sweat glands, sebaceous glands, 
mebomian glands, anal glands, and preputial glands. Alopecia 
behind ears, hairless tail with kink. Severe osteopetrosis, 
alymphoplasia, abnormal B cells, impaired IL1R and TLR 
signaling. 
(Naito et al., 2002) 
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FIGURE LEGENDS 
 
Fig. 1: Protein organisation and mode of action of the ligand and receptor pair EDA1-
EDAR and some of their agonists and antagonists. 
A.- Structural organisation of EDA1, EDAR and EDARADD. HED- and STA-causing mutations 
are those listed in UniProt. DD: death domain. 
B.- Principle of EDAR activation by endogenous EDA1. 
C.- Principle of action of soluble agonists and antagonists of the EDA - EDAR pathway. 
D.- Principle of in utero delivery of agonists and antagonists of EDAR signalling via 
transplacental antibody transport. 
 
Fig. 2: Naïve view of signalling pathways involved in hair and tooth morphogenesis at 
placode or bud stages. 
EDA and EDAR are important targets of canonical Wnt signalling in the epithelium. EDAR in 
turn stimulates NF-κB-mediated transcription of genes acting in major hair and tooth 
development pathways: Wnt (Wnt10a/b and the antagonist Dkk4), Hedgehog (Shh), TGFβ (the 
antagonists Follistatin or CTGF) and FGF (Fgf20). Components of these pathways and some of 
their relationships are also illustrated. 
 
Fig. 3: Long-term improvement of ectodermal dysplasia features by EDAR agonists in Eda-
deficient mice. 
Long-term reversion of hair (tail, guard, retro-auricular), eye and functional sweat glands in a 21 
months-old Eda-deficient mouse treated at days 8.5 and 13.5 of gestation with 4 mg/kg of an 
agonist anti-EDAR monoclonal antibody (mAbEDAR3 (Kowalczyk et al., 2011)).  
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